Tine Vanhaverbeke

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Knee Osteoarthritis

Chronic Kidney Disease

Top Venues

Nature medicine

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Marion C Kortekaas, Tine Vanhaverbeke, Helen Isobel Keen, Lene Terslev, Hilde Berner Hammer, Maria Antonietta D'Agostino, Ruth Wittoek, null null
Validation of HAND OA US inflammatory and structural damage score (HOUSE) for thumb base joints: Systematic review on truth & discrimination. Rheumatology (Oxford, England) (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine 30 (3) (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine 30 (3) (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine 30 (3) (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine 30 (3) (2024)
Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, Dirk Elewaut
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nature medicine 30 (3) (2024)